ICER issues final report and policy recommendations on acute treatments for migraine

25 February 2020 - Evidence on new agents lasmiditan, ubrogepant, and rimegepant judged inadequate to demonstrate superiority over more affordable triptans. ...

Read more →

TLV has decided on a policy for patient participation

21 February 2020 - TLV has taken another step in developing patient participation by developing a policy.  ...

Read more →

FundaPen initiative extended to all Kiwis in need of life-saving Epipen auto-injectors

24 February 2020 - The FundaPen campaign, which last year saw hundreds of free EpiPens® given to children in need, ...

Read more →

Senate Republican gets on board with government drug price negotiations

25 February 2020 - Arizona Sen. Martha McSally is introducing a drug pricing bill this week that would allow Medicare to ...

Read more →

Perrigo and Catalent announce FDA approval of Perrigo's AB-rated generic version of ProAir HFA

24 February 2020 - Perrigo and its partner, Catalent Pharma Solutions, today announced that the U.S. FDA has approved Perrigo's abbreviated ...

Read more →

Lysogene receives FDA fast track designation for LYS-SAF302 gene therapy in MPS IIIA

25 February 2020 - 17th patient dosed in the ongoing phase 2/3 AAVance study. ...

Read more →

VA could lead way for nation on lower drug pricing

24 February 2020 - It is no secret that prescription drug prices are a hot-button issue — and understandably so.  ...

Read more →

FDA accepts Genentech’s biologics license application for fixed-dose subcutaneous combination of Perjeta and Herceptin for HER2-positive breast cancer

24 February 2020 - Fixed-dose combination is administered under the skin in just minutes, compared to hours with intravenous administration, significantly ...

Read more →

What states are doing to combat rising prescription drug prices

24 February 2020 - Prescription drug-price transparency alone is not enough to stem skyrocketing costs, but it is considered an important ...

Read more →

Everyone wants to help, but still the red tape prevents Dylan Barker getting medicine

25 February 2020 - Dylan Barker lives with a rare genetic condition turning muscles, tendons and ligaments to bone, locking ...

Read more →

EMA publishes agenda for 24-27 February CHMP meeting

25 February 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

FDA approves first generic of ProAir HFA

24 February 2020 - Agency supports development of complex generic drugs to improve competition and access to more affordable medicines. ...

Read more →

Brexit - implications for therapeutic goods in Australia

25 February 2020 - A transition period is in effect until the end of 2020 while the UK and EU negotiate ...

Read more →

Alberta’s switch to biosimilar drugs may pose legal challenges for doctors

24 February 2020 - Prescribing cheaper medications for arthritis, diabetes or Crohn’s disease could be at odds with physicians’ legal requirement ...

Read more →

Digital therapeutics leaders focus on reimbursement

23 February 2020 - This past week the Digital Therapeutics West conference was held in Silicon Valley. CEOs, venture capitalists, and ...

Read more →